Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 19,750 | 15,374 | 0 | 9,530 |
| Operating Income | -19,750 | -15,374 | N/A | -9,530 |
| Other Income | 2,701 | 2,867 | 0 | -13,315 |
| Pre-tax Income | -17,049 | -12,507 | 0 | -22,845 |
| Income Tax | N/A | 1 | N/A | 0 |
| Net Income Continuous | -17,049 | -12,508 | N/A | -22,845 |
| Net Income | $-17,049 | $-12,508 | $N/A | $-22,845 |
| EPS Basic Total Ops | -19.01 | -18.94 | N/A | -38.23 |
| EPS Basic Continuous Ops | -19.01 | -18.95 | N/A | -38.23 |
| EPS Diluted Total Ops | -19.01 | -18.94 | N/A | -38.23 |
| EPS Diluted Continuous Ops | -19.01 | -18.95 | N/A | -38.23 |
| EBITDA(a) | $-19,737 | $-15,361 | $N/A | $-9,530 |